Greater baseline disease pruritus and quality of life impairment are associated with higher rates of super response to dupilumab in patients with AD.
Patients with HS with severe disease have greater cardiometabolic risk factors and ASCVD risk than patients with mild or moderate disease.
Individuals diagnosed with chronic spontaneous urticaria (CSU) are at a moderately increased risk of multiple cardiovascular ...
Experts discuss the importance of safe, effective topical therapies for long-term management of atopic dermatitis, ...
Clinical Trials Arena on MSN
Eli Lilly’s Ebglyss shows sustained skin clearance in atopic dermatitis trial
Eli Lilly has reported that its interleukin-13 (IL-13) inhibitor Ebglyss (lebrikizumab-lbkz) showed sustained skin clearance ...
Pfizer Inc (($PFE)) announced an update on their ongoing clinical study. Pfizer Inc. is currently conducting a Phase 1 clinical study titled ‘A ...
This story is part of the KXAN Data Hub, where numbers help tell the whole story. We’ve created several data-driven stories and databases on topics including weather and climate, politics, education, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback